Surface Modification of Sulfonated Carbon Fiber-Reinforced Polyetheretherketone Composite by Polydopamine-Assisted nHA/Zn/CMCS and Its Evaluation of Osteogenic Properties Authors: Aiqing Zhang, Yichang Cao, Huishan Zhao, Dangchao Sun, Lina Gao, Xiaqing Liu, Hui Jia, Qi Yang, Shuwei Gao, Binpeng Zhang, Haiyan Du, Ying Li Published: 2026 ABSTRACT AbstractObjectiveCarbon fiber-reinforced polyetheretherketone (CF/PEEK) possesses the elastic modulus similar to that of natural bone, yet its inherent surface hydrophobicity and bio-inertness restrict its application in oral implantation. To overcome this limitation, this study proposes the layer-by-layer surface functionalization strategy to construct the multifunctional CF/PEEK-based composite that integrates long-term antibacterial activity with synergistic osteogenic functions.MethodsAfter sulfonation of CF/PEEK with 98% H₂SO₄, the polydopamine-assisted nanohydroxyapatite (PDA-nHA) intermediate layer and the zinc-loaded carboxymethyl chitosan (Zn/CMCS) coating were sequentially constructed, yielding the SCP-PHA-Zn/CMCS composite. A series of Characterizations including surface morphology, in vitro mineralization, antibacterial evaluation, cytocompatibility, osteogenic property, and osteogenesis-related gene mRNA expression levels were performed to assess in vitro biocompatibility and osteogenic performance.ResultsSEM showed SCP-PHA-Zn/CMCS possessed the 3D porous network, with uniformly deposited PDA-nHA presenting a fibrous network after Zn-CMCS wrapping. After SBF immersion, spherical apatite particles deposited on all samples. Water contact angles of SCP-PHA and SCP-PHA-Zn/CMCS were significantly lower than SCF/PEEK. SCP-PHA-Zn/CMCS significantly inhibited Staphylococcus aureus and Escherichia coli. All groups showed good biocompatibility and long-term biosafety. rBMSCs on SCP-PHA-Zn/CMCS showed the highest adhesion density, proliferation, ALP activity, matrix mineralization, and osteogenesis-related gene mRNA expression levels, significantly outperforming the other groups and demonstrating the best in vitro osteogenic capacity.ConclusionTo address the surface hydrophobicity and bioinertia of CF/PEEK, this study successfully constructed the multifunctional SCP-PHA-Zn/CMCS composite using sulfonation pretreatment and the layer-by-layer functionalization assembly strategy. The obtained material exhibited favorable physicochemical properties, excellent biocompatibility and antibacterial performance, and significantly promoted the adhesion and proliferation of rBMSCs, enhanced ALP activity, matrix mineralization, and osteogenesis-related gene mRNA expression levels, demonstrating outstanding in vitro osteogenic capacity. These findings provide experimental evidence and a novel design strategy for the clinical translation of CF/PEEK in oral implantation and bone defect repair.Key words: Carbon fiber-reinforced PEEK, Nano-hydroxyapatite, Zinc-loaded carboxymethyl chitosan, Antibacterial activity, Osteogenic differentiation Introduction The success of dental implants depends on the establishment of the stable and functional connection between the artificial material and the surrounding bone tissue, the process is referred to as osseointegration.1 Titanium alloys have been widely used as dental implant materials due to their excellent biocompatibility and mechanical strength. However, the large difference of elastic modulus between titanium (>100 GPa) and cortical bone (7-30 GPa) will cause the stress shielding, which further results in bone resorption around the implants.2, 3, 4 Moreover, allergic reaction triggered by metal ion release and material corrosion has driven researchers to develop bioinert materials with bone-like mechanical properties.5, 6, 7, 8 Carbon fiber-reinforced polyetheretherketone (CF/PEEK) exhibits outstanding chemical stability, radiopacity and elastic modulus, with an elastic modulus comparable to natural bone tissue, which can effectively address the stress shielding issue.9, 10, 11 However, the inherent bioinertness and strong hydrophobicity of the pristine PEEK surface inhibit cellular compatibility and osseointegration severely, limiting its clinical translation in demanding applications such as dental implants.12 To construct the bioactive surface, sulfonation treatment with concentrated sulfuric acid has been verified as one efficient approach, which can fabricate the 3D networks on the CF/PEEK surface, elevate surface energy and provide interlocking sites for bone ingrowth.13, 14, 15 Nevertheless, sulfonation treatment is not sufficient to endow materials with robust osteogenic and antibacterial capacities, which are critical for the long-term success of implants in the complex and infection-prone oral microenvironment.16,17 Thus, this work adopted a layer-by-layer surface functionalization strategy to modify SCF/PEEK via a dual-functional coating, which comprised the PDA-nHA interlayer and the Zn/CMCS outer layer, thereby enhancing its osteogenic activity and antibacterial performance. The rationale for selecting these materials to modify SCF/PEEK was based on the following considerations. Polydopamine (PDA), as the core component of mussel adhesive proteins, is abundant in active functional groups such as catechol and amino organic groups. These organic groups not only can improve the hydrophilicity of the material surface, but also can construct multifunctional molecular anchoring platform for immobilizing the subsequent active components.18, 19, 20, 21 Nanohydroxyapatite (nHA) mimics the composition of natural bone mineral and efficiently induces the deposition of bone-like apatite.22, 23, 24 In addition to these osteoconductive properties, nHA exhibits a high specific surface area, excellent solubility, and remarkable bioactivity. Its unique surface topography provides topographical guidance for cell growth.25 Furthermore, nHA can continuously release calcium and phosphate ions in vivo, which directly stimulates osteogenic differentiation, enhances alkaline phosphatase (ALP) activity, and thereby accelerates bone tissue mineralization and regenerative repair.26, 27, 28 Finally, the dual antibacterial mechanism of zinc-loaded carboxymethylchitosan (Zn/CMCS), combining physical barrier effects and chemical bactericidal activity, effectively addresses the common issue of postoperative peri-implant bacterial infection in oral implants. On the one hand, CMCS forms a dense hydrophilic film on the material surface, which inhibits nonspecific protein adsorption and exerts electrostatic repulsion against negatively charged bacterial surfaces, thereby effectively blocking initial bacterial adhesion.29, 30, 31, 32 On the other hand, CMCS stabilizes and controllably releases Zn²⁺ through chelation via carboxyl and hydroxyl groups on its molecular chains. This process relies on a reversible dissociation and reassociation equilibrium of coordination bonds, which maintains the local free Zn²⁺ concentration above the MIC threshold over a prolonged period, ensuring sustained antibacterial activity while avoiding the cytotoxicity caused by early burst release. Based on this sustained release profile, the released Zn²⁺ exerts antibacterial effects through multiple pathways, including disruption of bacterial membrane integrity, interference with key enzymatic systems, induction of intracellular oxidative stress, and inhibition of quorum sensing and biofilm formation.33, 34, 35, 36 The synergistic action of physical barrier and chemical ion release provides sustained and efficient anti-infection protection for oral implants. Additionally, Zn²⁺ plays a dual regulatory role in bone metabolism. It promotes osteoblast proliferation and differentiation by activating the Wnt/β-catenin and BMP/Smad signaling pathways, while simultaneously inhibiting the NF-κB pathway to reduce osteoclast activity and bone resorption.37, 38, 39, 40, 41 The surface physicochemical properties including hydrophilicity, mineralization capacity, antibacterial performance, and osteogenic activity of the prepared samples were investigated through scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDS), contact angle measurement, and in vitro mineralization testing etc. The results demonstrate that this layer-by-layer modification strategy effectively overcomes the inherent bio-inertness and hydrophobicity of pristine CF/PEEK, while endowing the material with integrated antibacterial and osteogenic properties. This strategy is expected to provide a practical and feasible surface modification approach for developing high-performance CF/PEEK-based dental implants, and also offers valuable insights for the design of multifunctional bioactive coatings on polymer-based implant materials. Materials and methods Materials and reagents Nano-hydroxyapatite (nHA), dopamine hydrochloride, zinc chloride solution, and carboxymethyl chitosan (CMCS, 0.5% w/v) were purchased from Macklin Biochemical Co., Ltd. (Shanghai, China). Tris-HCl buffer (10 mM, pH 8.5) was obtained from Aladdin Reagent Co., Ltd. (Shanghai, China). Carbon fiber-reinforced polyetheretherketone (CF/PEEK) was supplied by Victrex plc (UK). Concentrated sulfuric acid (98%) was provided by Tianjin Kemiou Chemical Reagent Co., Ltd. (Tianjin, China). Simulated body fluid (SBF), penicillin-streptomycin, TRITC-conjugated phalloidin staining solution, DAPI staining solution, Alizarin Red S (ARS) staining solution, and 10% cetylpyridinium chloride solution were all purchased from Solarbio Science & Technology Co., Ltd. (Beijing, China). Fetal bovine serum was obtained from Gansu Cellmax Biotechnology Co., Ltd. (Gansu, China). Cell Counting Kit-8 (CCK-8) was purchased from Boster Biological Technology Co., Ltd. (Wuhan, China). Live/Dead cell staining kit was supplied by Dalian Meilun Biotechnology Co., Ltd. (Dalian, China). Osteogenic induction medium was purchased from Wuhan Procell Life Science & Technology Co., Ltd. (Wuhan, China). Alkaline phosphatase staining kit and alkaline phosphatase activity assay kit were obtained from Beyotime Biotechnology Co., Ltd. (Shanghai, China). Total RNA extraction kit and M5 Super qPCR RT reverse transcription kit were provided by Beijing Juhemei Biotechnology Co., Ltd. (Beijing, China). Preparation of PDA-modified nHA (PHA) nHA was dispersed in Tris-HCl buffer containing 2 mg/ml dopamine hydrochloride, which was ultrasonicated and magnetically stirred for 12 h in the dark at room temperature to facilitate the self-polymerization of dopamine. The pH 8.5 was chosen not only as the optimal condition for dopamine oxidation and polymerization into PDA, but also to render the nHA surface negatively charged, which promotes electrostatic attraction toward the positively charged dopamine intermediates and PDA species, thereby favouring a uniform PDA coating. The product was centrifugated at 9000 rpm and washed with deionized water to remove the residual reactants. Finally, the product was freeze-dried to obtain the PDA-modified nHA, named as PHA. Surface functionalization of SCF/PEEK Based on our previous study, the CF/PEEK substrates were sulfonated by treatment with 98% concentrated sulfuric acid under ultrasonication at room temperature for 5 min, yielding sulfonated carbon fiber-reinforced polyetheretherketone (SCF/PEEK). The resulting SCF/PEEK was then immersed in an aqueous suspension of PHA (4 g/L) and allowed to react at room temperature in the dark for 12 h to ensure uniform deposition of PHA on the SCF/PEEK surface. After that, the samples were rinsed three times with deionized water and freeze-dried, obtaining the PDA-assisted nHA coating (SCP-PHA). The SCP-PHA samples were immersed in the carboxymethyl chitosan aqueous solution, adding ZnCl₂ solution in it. The final zinc ion concentration was 25 mM. The reaction was carried out at 37 °C for 12 h under continuous stirring. The final product SCP-PHA-Zn/CMCS was obtained after rinsing with deionized water and freeze-drying. Characterization The surface morphology of the SCF/PEEK, SCP-PHA, and SCP-PHA-Zn/CMCS composites was observed using scanning electron microscopy (SEM, model SU8010, Hitachi, Japan). All samples were sputter-coated with a thin gold layer before test. Elemental composition analysis was performed using energy-dispersive X-ray spectroscopy (EDS, X-MaxN, Oxford Instruments, UK). Water contact angle (WCA) measurement Static water contact angles of different sample were measured using a contact angle goniometer (OCA20, DataPhysics Instruments, Germany) at 25°C. The deionized water droplet (2 μL) was carefully dispensed onto the sample surface, recording the contact angle. Three measurements were carried out for each group, and the results are presented as mean ± standard deviation. In vitro mineralization test Three groups of samples were immersed separately in simulated body fluid at 37 °C for 14 d, with the SBF solution replaced every 3 d. The surface morphology of the samples was observed via SEM, EDS analysis was performed to detect the elemental composition. Each group of samples was measured three times, and the average values were taken for data analysis. Antibacterial performance evaluation Antibacterial activity was assessed via the plate count method, evaluating the inhibitory effects of Staphylococcus aureus (ATCC 6538) and Escherichia coli (ATCC 25922) on different composites surfaces. Each sample group was placed in microplates containing the corresponding bacterial suspension and normal saline, incubated at 37 °C for 8 h. 20 μL aliquot was spread onto agar plates, which were incubated at 37 °C for 24 h before colony counting. The same procedure was repeated for E. coli. The calculation formula was shown as following: Where NA is the average number of colonies in the control group (without composite materials) and NB is the average number of colonies in the experimental group. Each test was performed in triplicate and the mean value was determined. Cytotoxicity assay After sterilization, leachates of SCF/PEEK, SCP-PHA and SCP-PHA-Zn/CMCS samples were prepared following ISO 10993-5:2009. The L929 mouse fibroblast cell line was purchased from China Haixing Biotechnology Co., Ltd. (catalog number TCM-C749). The cells were cultured in DMEM complete medium with 10% fetal bovine serum and 1% penicillin-streptomycin, seeded into 96-well plates at 5×103 cells/well (n = 5), and incubated at 37 °C with 5% CO2 for 24 h until adhesion. The original medium was discarded, leachates of each group were added, and negative control (complete medium only) and positive control (complete medium with 7.5% DMSO) were set. The cells were further cultured for 1, 4 and 7 d, with medium replacement every 2 d. At each time point, cell viability was detected via CCK-8 kit: an appropriate volume of CCK-8 solution was added to each well, incubated at 37 °C for 1 h in the dark, and absorbance (OD) values at 450 nm were measured using a microplate reader (Molecular Devices, SpectraMax Plus3, USA). The relative growth rate (RGR) of cells was calculated according to the formula, and the cytotoxicity grade was determined with reference to Table 1. Table 1Cytotoxicity grading criteria based on RGR.Table 1 dummy alt textRGR(%)Cytotoxicity gradeCytotoxicity evaluation≥1000No cytotoxicity75∼991No cytotoxicity50∼742Mild cytotoxicity25∼493Moderate cytotoxicity1∼244Moderate cytotoxicity05Severe cytotoxicity Cytotoxicity grading criteria based on RGR. Separate aliquots of cells were seeded into plates and cultured with the leachates for 1, 3, and 5 d, followed by staining in strict accordance with the protocol provided by the Live/Dead Cell Staining Kit. Immediately after staining, the cells were observed and imaged using an inverted fluorescence microscope (Leica, IXplore Pro, Germany) to evaluate the viability and morphology of L929 cells. Cell adhesion and proliferation The rBMSCs used in this study were obtained from SD rats provided by the Laboratory Animal Center of Shanxi Medical University. All animal procedures were reviewed and approved by the Animal Ethics Committee of the Hospital of Stomatology, Shanxi Medical University (approval number KQDW-2025-011). rBMSCs were cultured to passage 3 (P3) at 37 °C with 5% CO2. Phenotypic identification was performed via flow cytometry (BD FACSCalibur, USA) using antibodies against positive markers (CD29, CD90) and negative markers (CD31, CD45). Only cells that met the phenotypic criteria of rBMSCs were used for subsequent experiments. The identified rBMSCs were seeded at a density of 5×103 cells/well into 96-well plates coated with the materials and cultured for 48 h. The cells were then stained with TRITC-phalloidin for cytoskeleton visualization, followed by nuclear counterstaining with DAPI. Cell adhesion morphology on the material surface was observed and imaged using an inverted fluorescence microscope. For the cell proliferation assay, rBMSCs were seeded and cultured using the same method described above. Cell viability was detected with the CCK-8 kit on 1, 4, and 7 d of culture: an appropriate volume of CCK-8 solution was added to each well, and after incubation, the absorbance (OD) values were measured at 450 nm using a microplate reader. Column charts of rBMSC proliferation activity were plotted based on the OD values. Alkaline phosphatase (ALP) activity rBMSCs were seeded into 24-well plates and cultured for 24 h until complete adhesion. The medium was then replaced with osteogenic induction medium containing sample leachates, with medium renewal every 2 to 3 d. On 7 and 14 d of culture, cells were stained using an alkaline phosphatase staining kit. Simultaneously, ALP activity was quantitatively determined using an ALP activity assay kit at the same time points. Matrix mineralization rBMSCs were seeded and cultured for 24 h until adhesion following the aforementioned method, then the medium was replaced with osteogenic induction medium containing material leachates, with medium renewal every 2 to 3 d for a total 21 d induction period. The cells were stained with Alizarin Red S (ARS) solution to observe calcium nodule formation. Subsequently, the stained calcium nodules were dissolved in 10% cetylpyridinium chloride solution, and the absorbance values were measured at 562 nm for quantitative evaluation of matrix mineralization degree. Osteogenic gene expression rBMSCs were seeded into 6-well plates at a density of 1 × 10⁵ cells/well and cultured in osteogenic induction medium containing sample leachates for 14 d. After incubation, total RNA was extracted using a total RNA extraction kit, with its concentration and purity determined subsequently. A 1 μg aliquot of total RNA was reverse-transcribed into cDNA using the M5 Super qPCR RT Kit. The mRNA expression levels of osteogenic-related genes (ALP, Runx-2, Col-I, OCN) and the reference gene GAPDH were detected via quantitative real-time PCR (RT‑qPCR). Specific primers for each gene were added to the reaction system, and the relative expression levels of target genes were calculated using the 2–ΔΔCt method. Primer sequences are listed in Table 2. Table 2Primer sequences for osteogenic genes analyzed by RT-qPCR.Table 2 dummy alt textGenesSequences of primer(5’-3’)ALPForward:CCTGGAGAATACGAAGTGACCAReverse: GTTGAAGGTAGTCGGGGTTTCRunx-2Forward:CACAGACAATACAGACCCAGTGCReverse: TCAGCAGGAGCAGTCAAGATCCol-IForward: CACCCTGAAAGTGCTGTGACReverse: CCAGGAGAACCAGCAAGTCOCNForward: CTGACAAAGCTTCATGTCCCAReverse: TCAGCCGAGCTTGCGTAAGGAPDHForward: TGATGGGTGTGACCAGAGReverse: GTCAATGAAGGGGTCGTTGAT Primer sequences for osteogenic genes analyzed by RT-qPCR. Statistical analysis All statistical analyses in this study were performed using SPSS software (version 27.0), and graphs were generated with GraphPad Prism (version 10). Quantitative data were expressed as mean ± standard deviation. Comparisons among multiple groups were analyzed by one-way analysis of variance (ANOVA), followed by Tukey’s post hoc test for multiple comparisons. A P < .05 was considered statistically significant. Results and discussion Surface characterization Significant difference was observed in the macroscopic images and microtopography for the samples before and after modification (Figure 1). Figure 1A showed CF/PEEK was black, however, SCF/PEEK turned white and exhibited a rough surface. Compared with that, SCP-PHA is brown-black, and SCP-PHA-Zn/CMCS maintained the similar appearance as SCP-PHA. SEM images in Figure 1B display the effect of different modifications on the surface structure. For SCF/PEEK, 3D porous network structure was constructed on the surface, forming distributed pores and loose porous morphology. For SCP-PHA, some pores were covered, and the surface roughness was reduced, nHA nanoparticles were observed. The dense and continuous polymer layer formed on the surface of SCP-PHA-Zn/CMCS, and nHA particles were coated, obtaining the relatively smooth and compact surface morphology. The aforementioned morphological evolution is closely related to the interfacial chemical properties of the suspension. The PHA suspension used in this study was prepared in Tris‑HCl buffer at pH 8.5. This weakly alkaline condition favors dopamine self‑polymerization and simultaneously renders the PHA particle surfaces negatively charged. According to literature reports, the zeta potential of PDA‑modified nanoparticles under neutral to weakly alkaline conditions is estimated to be in the range of −15 to −25 mV. The electrostatic repulsion arising from this negative charge effectively maintains particle dispersion stability and prevents agglomeration, thereby ensuring uniform deposition of PHA onto the porous SCF/PEEK surface. Subsequently, the introduction of CMCS and Zn²⁺ interacts with the PHA surface via electrostatic attraction, gradually forming a dense polymer overlayer, ultimately yielding a smooth and continuous SCP‑PHA‑Zn/CMCS surface. Fabrication and characterization of the composites. A, Digital photographs displaying the macroscopic appearance of the different samples. B, Representative SEM images revealing the surface microstructure of different samples. C, Bar graph showing the static water contact angles of different samples. Data are presented as mean ± SD (n = 3). As shown in Figure 1C, different functionalization treatments significantly regulated the surface wettability of the PEEK substrate. The contact angle (CA) of SCF/PEEK was approximately 80°, which indicates the sulfonation process created the porous structure but did not alter the dominant role of the intrinsic hydrophobic groups of PEEK.42 The surface hydrophilicity was improved after modification with PDA assisted nHA, the CA of SCP-PHA decreased significantly to 35° (P < .05). This is because the abundant hydroxyl and amino groups in the PDA chains and the inherent hydrophilicity of nHA increased the surface density of hydrophilic sites.43 With the further introduction of a Zn/CMCS coating, the contact angle of SCP-PHA-Zn/CMCS increased slightly to approximately 50°. However, it remained significantly lower than that of SCF/PEEK (P < .05), confirming that the material retained favorable hydrophilicity. The slight increase of contact angle was primarily attributed to the altered distribution of hydrophilic groups after the coordination between Zn2+ and CMCS. In addition, the partial coverage of some nHA particles by the coating led to a moderate reduction in hydrophilic site density. In summary, the PDA-nHA modification effectively enhanced the hydrophilicity of composite. The incorporation of Zn/CMCS improved antibacterial functionality but did not weaken hydrophilic nature, achieving a balance between wettability performance and functionalization. Surface biomineralization In Figure 2, the in vitro bioactivity of various modified samples was evaluated through immersion tests in SBF. As an internationally standardized tool (ISO 23317) for evaluating the in vitro mineralization capacity of biomaterials, simulated body fluid (SBF) can effectively reflect the osseointegration potential through the induction of apatite deposition. Therefore, this system was adopted as the starting point for in vitro bioactivity assessment in this study. SEM observation revealed that mineralized products were observed on the surfaces of all samples. Notably, the surfaces of SCP-PHA and SCP-PHA-Zn/CMCS exhibited significant accumulation of typical spherical apatite particles. Quantification of the mineralized surface coverage showed that both the SCP-PHA and SCP-PHA-Zn/CMCS groups had significantly greater mineralized area proportions than the SCF/PEEK group, with statistically significant differences. Quantitative analysis based on EDS results revealed that the relative calcium (Ca) content of the two composites increase, indicating a higher Ca/P ratio and more abundant mineral deposition compared to other samples. These SEM and EDS results demonstrate that the modification strategy, which combines sulfonation pretreatment with a PHA-Zn/CMCS composite coating, can successfully construct the highly bioactive surface on the CF/PEEK substrate, effectively inducing the deposition of apatite. The rapid nucleation and deposition of apatite are crucial for bone implant materials to achieve good osseointegration. Thus, the mineralization phenomenon directly reflects the excellent bone-bonding ability of the modified composites. Surface characterization after SBF immersion. A, SEM images showing the surface morphology of mineralized deposits on different samples after soaking in SBF. B, Corresponding EDS spectra confirming the elemental composition of the deposited layer. C, Quantification of mineralized area fraction for the three groups. **P < .01, ***P < .001 relative to SCF/PEEK group. Antibacterial properties As shown in Figure 3, the antibacterial performance of the composites against S. aureus and E. coli was evaluated using the plate counting method. S. aureus is the most common and highly pathogenic Gram-positive bacterium in peri-implant infections. It readily adheres to implant surfaces and forms dense biofilms, and it is considered the primary pathogen responsible for peri-implantitis and even implant failure. E. coli, as a typical Gram-negative opportunistic pathogen, is often involved in mixed peri-implant infections in patients with compromised immune function or poor oral hygiene. Its cell wall possesses a unique lipopolysaccharide outer membrane, which gives rise to marked differences in membrane permeability and resistance mechanisms compared with Gram-positive bacteria. Selecting these two strains as indicator organisms covers both Gram-positive and Gram-negative categories, thereby enabling a comprehensive assessment of the breadth of the material’s antimicrobial spectrum. This approach also conforms to the international standard ISO 10993-5 and the general screening practices used in most antimicrobial biomaterial studies, thus ensuring that the experimental results are comparable and broadly applicable. Compared with SCF/PEEK, the quantitative colony counting results on SCP-PHA showed no statistically significant difference, and neither material exhibited significant antibacterial effects, indicating that sulfonation treatment and nHA loading did not confer antibacterial properties to the materials. But the SCP-PHA-Zn/CMCS significantly reduced the bacterial load of both strains (P < .0001). Based on the colony counting results, the antibacterial rates of SCP-PHA-Zn/CMCS against S. aureus and E. coli were calculated to be 76% ± 4.38% and 70% ± 5.89%, respectively, indicating greater efficacy against the Gram-positive strain. The result confirmed the moderately strong and broad-spectrum antibacterial capacity. The enhanced activity is mainly attributed to the Zn/CMCS composite coating. This coating not only significantly broadened the antibacterial spectrum of the composite and but also exhibited stronger efficacy against S. aureus. This aligned with the clinical profile of this pathogen in oral implant-related infections. The sustained release of Zn²⁺ from the coating is identified as the key antibacterial mechanism, which offers potent activity alongside promising potential for clinical translation. Antibacterial activity of the SCP-PHA-Zn/CMCS composite. A, Photographs of colonial formation of S. aureus and E. coli on different samples after co-culture. B, Quantitative colony counting results of E. coli cultured with each group of samples. C, Quantitative colony counting results of S. aureus cultured with each group of samples. Bacterial viability is shown as log₁₀(CFU/mL). ns = not significant, ****P < .0001 relative to Control, mean ± SD. Evaluation of in vitro cytotoxicity The biocompatibility of the materials was assessed using the CCK-8 cytotoxicity assay, with live/dead staining for morphological verification. As shown in Figure 4A, the RGR% of all composites exceeded 85% after 1 d, corresponding to toxicity grade 1. This indicates the samples had no acute cytotoxicity. The RGR% of SCF/PEEK decreased significantly to 70.12% ± 3.51% on 4 d, and the toxicity grade raised to grade 2. In contrast, both SCP-PHA and SCP-PHA-Zn/CMCS maintained RGR% above 80%. The decline observed for SCF/PEEK was due to acidic residues from sulfonation and adsorbed degradation products within its porous structure, which may temporarily disrupt the cellular microenvironment. The stable performance of SCP-PHA and SCP-PHA-Zn/CMCS suggests that the incorporation of nHA and the Zn/CMCS coating effectively modulated the material interface, mitigating acidic residues through acid–base neutralization and optimizing the local microenvironment via sustained Zn²⁺ release and the hydrophilic nature of CMCS. On 7 d, the RGR% of all groups recovered to above 80% (toxicity grade 1). Notably, the proliferation activity of SCP-PHA-Zn/CMCS was significantly higher than that of SCF/PEEK (P < .01), further confirming that the composite modification synergistically enhanced biocompatibility. In vitro cytocompatibility evaluation of the SCP-PHA-Zn/CMCS composite. A, Relative growth rate (RGR) of cells cultured in extracts from different sample groups over time. Data are presented as mean ± SD (*P < .05, **P < .01, ***P < .001). B, Live/dead staining images of cells after 1, 3, and 5 d of culture (scale bar: 100 μm). Live/dead staining results (Figure 4B) further confirmed the above findings. The number of live cells increased on all material surfaces with prolonged culture, displaying well-spread morphology without noticeable dead-cell aggregation. SCP-PHA-Zn/CMCS showed the highest cell density. These morphological observations corroborated the quantitative assay results, demonstrating that none of three materials exhibited significant cytotoxicity. The modified groups, particularly SCP-PHA-Zn/CMCS, promoted superior cell spreading and proliferation. Thus, the multi-step surface modification strategy effectively ensured and enhanced the biocompatibility of the composites, establishing a critical biosafety foundation for its applications in vivo. Adhesion and proliferation of rBMSCs The rBMSCs were previously identified by surface marker analysis. As shown in Figure 5, the cells were positive for CD29 and CD90 but negative for CD31 and CD45, confirming the typical rBMSC immunophenotype. Moreover, it also indicated the cell purity could meet the requirements for the following osteogenic experiments. Flow cytometric analysis of rBMSCs for surface marker expression. Representative histograms or dot plots show the expression of characteristic positive (CD29 and CD90) and negative (CD31 and CD45) markers. Cell adhesion, the fundamental indicator of implant biocompatibility, serves as the basis for subsequent proliferation and differentiation. After 48 h of culture, fluorescence staining showed that cells adhered and spread on all material surface (Figure 6A). Compared with SCF/PEEK, both SCP-PHA and SCP-PHA-Zn/CMCS supported the higher number of cells, with more extensive spreading and more distinct cytoskeletal extensions. Among these, SCP-PHA-Zn/CMCS exhibited the highest cell density and the most favorable spreading morphology. Cell adhesion and proliferation on the SCP-PHA-Zn/CMCS composite. A, Fluorescence microscopy images of rBMSCs adhered to the surfaces of different samples after 48 h of culture (scale bar: 50 μm). B, Proliferation viability of rBMSCs cultured on various sample surfaces over time. Data are presented as mean ± SD (*P < .05, **P < .01, ***P < .001). Cell proliferation was assessed using the CCK-8 assay (Figure 6B). No significant difference was observed among groups on 1 d, both SCP-PHA and SCP-PHA-Zn/CMCS showed significantly higher proliferation activity than SCF/PEEK on 4 and 7 d (P < .01). SCP-PHA-Zn/CMCS demonstrated the most pronounced pro-proliferative effect. These results are consistent with the cytotoxicity assessment (Section 3.4), indicating that the SCP-PHA-Zn/CMCS provides the more favorable microenvironment for rBMSCs. It benefits the early proliferation and subsequent osteogenic differentiation. The superior cellular response of SCP-PHA-Zn/CMCS is closely related to its distinct surface physicochemical properties, including higher adhesion density, better spreading, and enhanced proliferation. On the one hand, the increased surface roughness caused by the modification provides more anchoring sites for cells and promotes the adsorption of adhesion-related proteins such as fibronectin, thereby facilitating cell spreading and proliferation.44,45 On the other hand, the zwitterionic structure of CMCS contain positively charged amino groups (–NH₃⁺) and negatively charged carboxyl groups (–COO⁻), which improves the surface hydrophilicity significantly. The enhanced hydrophilicity promotes the efficient adsorption and conformational optimization of serum proteins, improves the initial cell-material interaction, increases fibronectin adsorption efficiency, and ultimately enhances cell adhesion and spreading. Evaluation of osteogenic performance in vitro The osteogenic differentiation capacity on the implant surface is crucial for osseointegration. As shown in Figure 7, the osteogenic properties of composites were evaluated by measuring ALP activity, matrix mineralization, and the expression of osteogenesis-related genes, which serve as key markers at early and late stages of differentiation.46 After 7 and 14 d of culture, ALP staining intensity was significantly stronger on SCP-PHA-Zn/CMCS than SCF/PEEK and SCP-PHA. In vitro osteogenic efficacy of the SCP-PHA-Zn/CMCS composite. (A) Alkaline phosphatase (ALP) staining and (B) corresponding quantitative activity of rBMSCs cultured in sample extracts for 7 and 14 d. Data are presented as mean ± SD (*P < .05, **P < .01, ***P < .001). C, ARS staining of calcium nodules (scale bar: 200 μm) and (D) quantitative analysis of matrix mineralization in rBMSCs induced by sample extracts for 21 d. Data are presented as mean ± SD (*P < .05, **P < .01 vs SCF/PEEK group). Quantitative analysis further confirmed that the ALP activity of SCP-PHA-Zn/CMCS was significantly higher than other two groups at 14 d (P < .05). In the matrix mineralization assay on 21 d, SCP-PHA-Zn/CMCS exhibited more densely distributed mineralized nodules, with the significantly higher quantitative mineralization value (P < .05). Moreover, osteogenesis-related gene mRNA expression levels revealed that on 14 d, SCP-PHA-Zn/CMCS showed significant upregulation of the early marker Alp, the key transcription factor Runx2, and the late-stage markers OCN and Col-I compared to the other groups (P < .05) (Figure 8). The above results indicate that SCP-PHA-Zn/CMCS effectively promotes the osteogenic differentiation of rBMSCs. Expression of osteogenesis-related genes in rBMSCs cultured on modified and unmodified samples for 14 d. Data are presented as mean ± SD (*P < .05, **P < .01, ***P < .001, n.s., not significant). The superior osteogenic capability of SCP-PHA-Zn/CMCS can be attributed to its surface properties and component synergy. For one thing, the composite significantly improved initial cell adhesion and spreading, providing the physical foundation for differentiation. For another thing, nHA directly guides biomineralization. Its chemical composition is similar to that of natural bone, serving as the nucleation site for apatite deposition and accelerating the formation of the bone-like apatite layer. Meanwhile, the Ca²⁺ and PO₄³⁻ ions released during its degradation further supply essential precursors for extracellular matrix mineralization. Finally, CMCS enables the stable loading and sustained release of Zn²⁺ through the ion-exchange mechanism. This provides long-term, stable regulation of osteogenic differentiation while avoiding the cytotoxicity associated with burst release. The inherent bioactivity of chitosan derivatives further synergizes with Zn²⁺ and nHA, collectively enhancing the osteoinductive effect. Thus, due to its unique surface characteristics and multi-component synergy, SCP-PHA-Zn/CMCS demonstrates superior in vitro osteoinductive potential compared to SCF/PEEK, as evidenced by enhanced ALP activity, stronger matrix mineralization, and upregulation of osteogenic genes mRNA expression levels. These findings suggest its promising potential for the surface modification of oral implants. Limitations This study successfully endowed the composite with favorable antibacterial and osteogenic properties through a layer-by-layer self-assembly modification strategy, yet several limitations remain to be addressed in future work. The material characterization has not yet employed FTIR, XRD, or AFM to thoroughly analyze the chemical structure, crystalline composition, and 3D morphology of the coating. Key mechanical parameters, such as the bonding strength between the coating and the substrate as well as flexural strength, have also not been systematically evaluated. Moreover, the demonstration of sustained Zn²⁺ release still lacks direct support from dissolution kinetic data. From the perspective of clinical oral application, future studies should incorporate evaluations against key oral pathogens such as Streptococcus mutans and Porphyromonas gingivalis. In addition, cell experiments should include oral-derived cell lines such as human gingival fibroblasts or periodontal ligament stem cells. Furthermore, all biological evaluations are currently confined to in vitro experiments, and in vivo animal studies are needed to verify the actual osteogenic efficacy and biosafety of the material. Subsequent research will also extend the functional modification strategy developed in this work to biodegradable polymeric substrates, with the aim of developing material systems that possess both antibacterial and osteogenic functions and can eventually be completely absorbed by the body. Conclusions This work constructed the rough 3D porous structure on the surface of CF/PEEK through sulfonation treatment, obtaining SCF/PEEK as the substrate. The pretreatment not only optimized the surface microstructure of the material, but also provided the stable reactive interface for subsequent functionalization. Based on this, PDA-nHA was introduced as the functional interlayer followed by the stepwise deposition of the Zn/CMCS bioactive coating, ultimately yielding the surface-functionalized composite SCP-PHA-Zn/CMCS. The characterization results confirmed that the modified composite enhanced surface hydrophilicity significantly and induced the deposition of spherical bone-like apatite effectively, indicating markedly improved in vitro bioactivity. Moreover, the composite coating composed of PDA-nHA and Zn/CMCS effectively mitigated the potential cytotoxicity caused by sulfonation, ensuring its biosafety. Biological performance assessments revealed that the SCP-PHA-Zn/CMCS demonstrated excellent antibacterial efficacy against both S. aureus and E. coli, with increased inhibition rates and outstanding cytocompatibility. In terms of osteogenic properties, the SCP-PHA-Zn/CMCS promoted cell adhesion and proliferation, significantly elevated ALP activity, enhanced extracellular matrix mineralization, and upregulated the mRNA expression levels of osteogenesis-related genes. Therefore, through the layer-by-layer surface modification strategy using PDA-nHA and Zn/CMCS, the present work achieved the simultaneous enhancement of bioactivity, antibacterial performance, and osteogenic capability in SCF/PEEK. The functional composite will exhibite potential applications in oral bone repair and provide theoretical support for the clinical translation of CF/PEEK-based composites in the field of oral medicine. Data availability Data will be made available on request. Author statement We declare that this manuscript is original, has not been published before and is not currently being considered for publication elsewhere. We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. We further confirm that the order of authors listed in the manuscript has been approved by all of us. We understand that the Corresponding Author is the sole contact for the Editorial process. She is responsible for communicating with the other authors about progress, submissions of revisions, and final approval of proofs. Author contributions Conceptualization: Aiqing Zhang. Methodology: Aiqing Zhang, Yichang Cao. Data curation: All authors. Writing-original draft: Yichang Cao. Supervision: Xiaqing Liu, Hui Jia, Ying Li, Haiyan Du. Writing-review and editing: Ying Li, Haiyan Du Conflict of interest None disclosed. Acknowledgments Funding This research was financially supported by Shanxi Provincial Science and Technology Department (Grant No. 202203021211023). Acknowledgements We thank all participants for their voluntary involvement and dedication. Special appreciation goes to our colleagues and laboratory staff for their invaluable technical assistance and insightful discussions. We also recognize the contributions of the editorial and peer review process in refining this manuscript, and we are thankful for the constructive feedback received. Footnotes Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.identj.2026.109821. Contributor Information Haiyan Du, Email: duhaiyan428@163.com. Ying Li, Email: oliver1104@163.com. Supplementary materials REFERENCES Associated Data Supplementary Materials Data Availability Statement Data will be made available on request.